Last reviewed · How we verify
Commercial vaccine 2 — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Commercial vaccine 2 (Commercial vaccine 2) — Crucell Holland BV.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Commercial vaccine 2 TARGET | Commercial vaccine 2 | Crucell Holland BV | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Commercial vaccine 2 CI watch — RSS
- Commercial vaccine 2 CI watch — Atom
- Commercial vaccine 2 CI watch — JSON
- Commercial vaccine 2 alone — RSS
Cite this brief
Drug Landscape (2026). Commercial vaccine 2 — Competitive Intelligence Brief. https://druglandscape.com/ci/commercial-vaccine-2. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab